The Push for Digital Pathology
Covid-19 provides an unexpected catalyst for digital solutions.
Read MorePosted by Laurie Bonner | Aug 24, 2020 | Covid 19, Digital Pathology |
Covid-19 provides an unexpected catalyst for digital solutions.
Read MorePosted by Laurie Bonner | Aug 21, 2020 | Covid 19, Miscellaneous |
The tests affected are those developed by and used at laboratories regulated under the Clinical Laboratory Improvement Amendments program.
Read MorePosted by Melanie Hamilton-Basich | Aug 21, 2020 | Covid 19, Immunoassay Reagents & test Kits |
FDA has authorized the covid-19 antigen test for use in high and moderate complexity laboratories certified under CLIA and at the point of care.
Read MorePosted by Melanie Hamilton-Basich | Aug 20, 2020 | Covid 19 |
The ultra-high-volume covid-19 test approach may enable processing of over 40,000 patient samples per day using molecular barcodes for viral RNA.
Read MorePosted by Melanie Hamilton-Basich | Aug 20, 2020 | Biochemicals & Chemical Reagents, Covid 19 |
RayBiotech’s novel 1-Step Covid-19 PCR collection buffer allows for immediate use of the saliva and other sample types on authorized tests.
Read More